Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lines

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|August 20, 1994
Hazards of reducing cholesterolC Lines
Journal of Pharmaceutical and Biomedical Analysis|March 1, 1996
High-performance liquid chromatographic mapping of the oligosaccharides released from the humanised immunoglobulin, CAMPATH 1HA C Lines
Expert Opinion on Investigational Drugs|July 5, 2005
Rizatriptan: a new 5-HT1B/1D receptor agonist for the treatment of migraineC Dahlof, C Lines
Gut|April 29, 2008
Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programmeK E Nnoaham, C Lines
International Journal of Clinical Practice|May 1, 2004
Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tabletC Lines, W H Visser
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 24, 2006
FRS 1000, an extract of red onion peel, strongly inhibits phosphodiesterase 5A (PDE 5A)T C Lines, M Ono
Cephalalgia : an International Journal of Headache|March 21, 2002
Evidence-based migraine therapyC Lines, C Allen, K McCarroll
British Journal of Clinical Pharmacology|March 1, 1995
Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260C Lines, J Challenor, M Traub
Cephalalgia : an International Journal of Headache|October 18, 2002
Sum of Pain Intensity Differences (SPID) in migraine trials. A comment based on four rizatriptan trialsP Tfelt-Hansen, K McCarroll, C Lines
Headache|July 5, 2001
Effect of rizatriptan in the spectrum of headacheC Allen, R Cady, C Lines, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|August 20, 1994
Hazards of reducing cholesterolC Lines
Journal of Pharmaceutical and Biomedical Analysis|March 1, 1996
High-performance liquid chromatographic mapping of the oligosaccharides released from the humanised immunoglobulin, CAMPATH 1HA C Lines
Expert Opinion on Investigational Drugs|July 5, 2005
Rizatriptan: a new 5-HT1B/1D receptor agonist for the treatment of migraineC Dahlof, C Lines
Gut|April 29, 2008
Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programmeK E Nnoaham, C Lines
International Journal of Clinical Practice|May 1, 2004
Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tabletC Lines, W H Visser
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 24, 2006
FRS 1000, an extract of red onion peel, strongly inhibits phosphodiesterase 5A (PDE 5A)T C Lines, M Ono
Cephalalgia : an International Journal of Headache|March 21, 2002
Evidence-based migraine therapyC Lines, C Allen, K McCarroll
British Journal of Clinical Pharmacology|March 1, 1995
Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260C Lines, J Challenor, M Traub
Cephalalgia : an International Journal of Headache|October 18, 2002
Sum of Pain Intensity Differences (SPID) in migraine trials. A comment based on four rizatriptan trialsP Tfelt-Hansen, K McCarroll, C Lines
Headache|July 5, 2001
Effect of rizatriptan in the spectrum of headacheC Allen, R Cady, C Lines, et al.
Pageof 3